Condition
Limbus Corneae
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07288658Phase 4CompletedPrimary
Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones
NCT02886611RecruitingPrimary
Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation
NCT04773431Phase 1CompletedPrimary
Safety Evaluation of LSCD101 Transplantation for Limbal Stem Cell Deficiency
NCT02500134UnknownPrimary
Using AS-OCT to Assess the Role of Age and Region in the Morphology and Epithelial Thickness of Limbus
Showing all 4 trials